Efficacy of GSK Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 against TB Disease in Healthy Adults Living in a TB Endemic Region (ZAMBIA)

Grant

Date/time Interval

  • August 1, 2015 - July 31, 2016
  • Total Award Amount

  • 44869.00
  • Direct Costs

  • 40791.00
  • Sponsor Award Id

  • 018(115616) SA1
  • Contributor

  • German Henostroza   Principal Investigator